Torque Teno Virus: A Biomarker of Immunosuppression
Launched by QUEEN MARY UNIVERSITY OF LONDON · Feb 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the relationship between a virus called Torque Teno Virus (TTV) and how well the immune system is working in people who have received a kidney transplant. Researchers want to see if the levels of TTV in the blood can help identify if a patient is getting too much or too little medication that suppresses their immune system. This is important because the right balance of immunosuppression can help prevent kidney rejection and other infections.
If you are a kidney transplant recipient aged 18 or older and are willing to participate, you could be eligible for this study. There are no specific exclusions, so most people will qualify. Participants will provide blood samples to measure TTV levels and other immune cells in their bodies. This research aims to improve the care for kidney transplant patients by helping doctors understand how to better manage their medications and reduce the risk of complications.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All consenting renal transplant recipients in the study period will be included in the study
- Exclusion Criteria:
- • no exclusion criteria.
About Queen Mary University Of London
Queen Mary University of London is a prestigious research-intensive institution recognized for its commitment to advancing medical science and improving health outcomes. As a leading sponsor of clinical trials, the university harnesses its academic excellence and innovative research capabilities to explore groundbreaking treatments and therapies across various medical disciplines. With a focus on collaboration, the institution engages with a diverse network of clinicians, researchers, and industry partners to ensure rigorous study design, ethical conduct, and the translation of research findings into clinical practice. Queen Mary University of London is dedicated to contributing to the global body of knowledge in healthcare through high-quality clinical research that prioritizes patient safety and welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials